补肝肾健脾温针灸法防治原发性骨质疏松症及骨量减少的临床研究

目的:探讨补肝肾健脾温针灸法防治原发性骨质疏松症及骨量减少的作用。方法:分别将原发性骨质疏松症63例随机分为针灸治疗组32例和药物治疗组31例,骨量减少患者40例随机分为针灸防治组20例和药物防治组20例,针灸治疗组和防治组均选取大杼、肝俞、肾俞、足三里、阳陵泉、三阴交、悬钟、关元,予针灸治疗,隔日1次,治疗45天次;药物组口服维丁钙片,4片/次,3次/d,连续3个月。观察各组治疗前后的骨密度(BMD)、骨钙素(BGP)、骨痛积分、衰老积分及临床疗效。结果:治疗结束后3个月,针灸治疗组的L2-L4、左股骨Neck、Ward区及GT骨密度较治疗前均有明显增加(P<0.01,或P<0.05);药物治疗组左股骨Ward区骨密度较治疗前有明显变化(P<0.01),左股骨L2-L4、Neck骨、GT部位的密度较治疗前轻微增加,但差异无显著意义,两治疗组间比较差异有统计学意义。骨量减少防治结束后3个月,针灸防治组L2-L4、股骨Neck、Ward区及GT骨密度值与药物组比较,差异均有统计学意义(P<0.05)。针灸和药物治疗骨质疏松症患者及针灸和药物防治骨量减少患者3个月后,BGP较治疗前均有不同程度降低(P<0.01),且针灸组与药物组BGP降低差异有统计学意义(P<0.05)。针灸和药物治疗组、针灸和药物防治组治疗后骨痛积分和衰老积分较治疗前降低(P<0.05,P<0.01),针灸治疗、防治组与药物组治疗、药物防治组治疗前后骨痛积分、衰老积分差值比较,差异有统计学意义(P<0.05,P<0.01)。针灸治疗组的临床控制率为25.0%、药物治疗组为3.25%,针灸防治组的临床控制率为35%,药防治物组为10%,针灸治疗、防治组疗效优于药物治疗、防治组(P<0.01,P<0.05)。结论:补肝肾健脾针法治疗骨质疏松症及防治骨量减少在提高骨密度、改善骨代谢、降低骨痛积分,改善衰老症状,改善临床症状上优于口服维丁钙片。该针灸疗法对防治原发性骨质疏松症及骨量减少,延缓衰老有明显的优势。

Clinic Research of the Bu GanShen Jian Pi Acupuncture and Moxibustion Therapy on Primary Osteoporosis and the Reduction of Bone Mass Density

Objective:To study the clinical effect and mechanism of theBu GanShen Jian Pi Acupuncture and Moxibustion therapy on primary osteoporosis and the reduction of bone mass density.Methods:63 cases of primary osteoporosis rangdomly divided into the treatment groups for 32 cases and the control group for 31cases,and 40 cases ofthe reduction of bone mass density were rangdomly and equally divided into a prevention group and a control group.The treatment and the prevention groups were treated by acupuncture and mo...